Sign in now to see personalised content appear here.

You can also see your reading history and subscription details on your subscriber page.

Why subscribe?
Find out more.

Sign up for your FREE email newsletter  +


Mylan to acquire Renaissance's speciality and generic topical business

Mylan is acquiring the business on a cash-free, debt-free basis and expects to finance the transaction using a combination of cash and available borrowings under existing credit facilities

R and D | Generics | Therapeutic Sector | Finance

Mercia makes follow-on investment in Medherant's transdermal technology

Medherant’s TEPI-patch is a thin, strong, easy-to-apply and easy-to-remove patch capable of delivering higher doses of drugs directly to the areas where they are needed

Europe | Drug Delivery | R and D | Finance

An injection of innovation

Removing water from drugs such as vaccines and other injectables (lyophilisation) and sealing the material in a vial makes it easier to transport drugs around the world, particularly where cold storage chains are less reliable. Such products, however, require an additional preparation step of recon

Packaging | Europe | Vaccines | Manufacturing and Equipment

US aseptic packaging demand to reach US$6.4bn in 2020

Growth will be driven by advances in processing, as well as the ability of products in aseptic packaging to be distributed and stored at ambient temperatures

Packaging | North America

US demand for drug delivery products to reach US$251bn

Demand for drug delivery products in the US is projected to increase 6.1% annually to reach US$251bn in 2019

North America | Drug Delivery

Transdermal patch market grows to US$7bn

New applications continue to emerge for transdermal drug delivery, including migraine, HIV, osteoporosis, stroke and restless leg syndrome treatments

Drug Delivery | Finance

BD divests Rx business and adds IV solutions

BD and Fresenius Kabi have also signed a 10-year supply and distribution agreement

North America | Finance | Manufacturing and Equipment